PE20011131A1 - Compuestos tetraciclicos no esteroides para tratamientos relacionados con estrogenos - Google Patents

Compuestos tetraciclicos no esteroides para tratamientos relacionados con estrogenos

Info

Publication number
PE20011131A1
PE20011131A1 PE2001000283A PE2001000283A PE20011131A1 PE 20011131 A1 PE20011131 A1 PE 20011131A1 PE 2001000283 A PE2001000283 A PE 2001000283A PE 2001000283 A PE2001000283 A PE 2001000283A PE 20011131 A1 PE20011131 A1 PE 20011131A1
Authority
PE
Peru
Prior art keywords
estrogen
alkenyl
alkyl
compounds
optionally
Prior art date
Application number
PE2001000283A
Other languages
English (en)
Inventor
Hubert Jan Jozef Loozen
Eduard Willem
Gerrit Herman Veeneman
Jordi Mestres
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PE20011131A1 publication Critical patent/PE20011131A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/21—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS 11H-BENZO[b]FLUORENO; 11H-INDENO[1,2-b]QUINOLINA; BENZ[a]ANTRACENO DE FORMULA I DONDE Ra O Rb ES Re; Re Y Re' SON OH OPCIONALMENTE ESTERIFICADO O ETERIFICADO; X ES N, CR1; R1 Y R2 SON H, HALOGENO, CN, ARILO, ALQUILO C1-C4, ALQUENILO C2-C4, ALQUINILO C2-C4, CICLOALQUILO C3-C6 OPCIONALMENTE SUSTITUIDOS POR HALOGENO; Y ES N, CR2; X E Y NO SON N A LA VEZ; Z ES C(R3,R3'); C(R4,R4)'-C(R5,R5'); R3; R4, R4'; R5; R5' SON H, ALQUILO C1-C4, ALQUENILO C2-C4, CICLOALQUILO C3-C6 OPCIONALMENTE SUSTITUIDOS POR HALOGENO. LOS COMPUESTOS NO ESTEROIDES SON MODULADORES DE LOS RECEPTORES DE ESTROGENOS Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE OSTEOPOROSIS,, OTRAS MOLESTIAS POSTMENOPAUSICAS, ANTICONCEPCION
PE2001000283A 2000-03-27 2001-03-26 Compuestos tetraciclicos no esteroides para tratamientos relacionados con estrogenos PE20011131A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201105 2000-03-27
EP00201103 2000-03-27

Publications (1)

Publication Number Publication Date
PE20011131A1 true PE20011131A1 (es) 2001-11-12

Family

ID=26072045

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000283A PE20011131A1 (es) 2000-03-27 2001-03-26 Compuestos tetraciclicos no esteroides para tratamientos relacionados con estrogenos

Country Status (9)

Country Link
US (1) US6686371B2 (es)
EP (1) EP1272471B1 (es)
JP (2) JP2003528858A (es)
AT (1) ATE374752T1 (es)
AU (1) AU2001254710A1 (es)
DE (1) DE60130748T2 (es)
ES (1) ES2293986T3 (es)
PE (1) PE20011131A1 (es)
WO (1) WO2001072713A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
CZ2003514A3 (cs) * 2000-08-23 2003-10-15 Akzo Nobel N. V. Fluorenové deriváty a jejich analogy
WO2003015761A1 (en) * 2001-08-13 2003-02-27 Merck & Co., Inc. Selective estrogen receptor modulators
EA007382B1 (ru) 2001-11-19 2006-10-27 Эли Лилли Энд Компани Замещенные бензопираны в качестве селективных агонистов бета-рецептора эстрогена
TW200408385A (en) * 2001-12-21 2004-06-01 Akzo Nobel Nv Tetrahydrobenzfluorene derivatives
TW200304371A (en) * 2002-02-22 2003-10-01 Akzo Nobel Nv Substituted 10-ary1-11H-benzo [b] fluorenes and 7-ary1-5, 6-dihydro-benz [a] anthracenes for selective effects on estrogen receptors
US6849348B2 (en) * 2002-12-31 2005-02-01 Eastman Kodak Company Complex fluorene-containing compounds
ATE457308T1 (de) 2003-04-21 2010-02-15 Lilly Co Eli Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta
CA2518819A1 (en) 2003-04-21 2004-11-04 Eli Lilly And Company Substituted benzopyrans as selective estrogen receptor-beta agonists
JP2008512458A (ja) 2004-09-07 2008-04-24 ワイス ６Ｈ−［１］ベンゾピラノ［４，３−ｂ］キノリン及びエストロゲン様物質としてのそれらの使用
WO2016031415A1 (ja) * 2014-08-27 2016-03-03 富士フイルム株式会社 組成物、膜、光学機器、化合物
CN104327088A (zh) * 2014-09-24 2015-02-04 大连理工大学 一种7-氯-6H-苯并吡喃[4,3-b]喹啉及其衍生物的制备方法
CN104262357B (zh) * 2014-09-24 2017-05-03 大连理工大学 一种7‑氯‑6H‑苯并噻喃[4,3‑b]喹啉及其衍生物的制备方法
CN104292243A (zh) * 2014-09-24 2015-01-21 大连理工大学 一种苯并噻喃[4,3-b]喹啉及其衍生物的制备方法
CN108947947A (zh) * 2017-05-17 2018-12-07 北京新领先医药科技发展有限公司 一种沃拉帕沙中间体的制备方法
CN115785148A (zh) * 2022-11-17 2023-03-14 江西科技师范大学 一种硫代膦（磷）酸酯取代苯并芴化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223506A (en) * 1991-06-04 1993-06-29 Glaxo Inc. Cyclic antitumor compounds
US5147880A (en) * 1991-07-22 1992-09-15 Eli Lilly And Company Benzo[a]fluorene compounds
US5688810A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
JP3141148B2 (ja) 1995-08-08 2001-03-05 大鵬薬品工業株式会社 縮合インダン誘導体及びその塩
NZ334954A (en) * 1996-09-23 2000-08-25 Univ Rutgers Substituted heterocycles as anti-tumor agents
MXPA05003446A (es) * 2002-10-01 2005-07-05 Dainippon Pharmaceutical Co Compuestos espiro, composiciones medicinales que contienen los mismos, e intermediarios de los compuestos.

Also Published As

Publication number Publication date
WO2001072713A1 (en) 2001-10-04
EP1272471B1 (en) 2007-10-03
EP1272471A1 (en) 2003-01-08
ES2293986T3 (es) 2008-04-01
JP2003528858A (ja) 2003-09-30
US6686371B2 (en) 2004-02-03
JP2009292824A (ja) 2009-12-17
DE60130748D1 (de) 2007-11-15
AU2001254710A1 (en) 2001-10-08
US20030144313A1 (en) 2003-07-31
ATE374752T1 (de) 2007-10-15
DE60130748T2 (de) 2008-07-17

Similar Documents

Publication Publication Date Title
PE20011131A1 (es) Compuestos tetraciclicos no esteroides para tratamientos relacionados con estrogenos
BR0009814A (pt) Processo para tratar de uma doença associada com o receptor-beta estrogênico
PE134199A1 (es) Inhibicion de la oxidacion de lipoproteinas
BR0212617A (pt) Compostos de pirazolila substituìdo para o tratamento de inflamação
BR0015532A (pt) Compostos
BR0113053A (pt) Uso de benzilidenoaminoguanidinas e hidroxiguanidinas como ligantes para os receptores de melanocortina
DK1446128T3 (da) Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling
PE20010126A1 (es) Pirrolotriazinas como inhibidores de cinasas
ATE344075T1 (de) Automatisch auslösbare schutzschildanordnung für spritzen
BR0212611A (pt) Compostos de pirazolila substituìdos para o tratamento da inflamação
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
BRPI0515546A (pt) compostos para inflamação e usos imune-relacionados
DE60014873D1 (de) Synergistische zusammensetzungen zur krebsbehandlung
SV1999000047A (es) Nuevas dihidropirimidinas fef. lea 32792-sv
AR027910A1 (es) Composicion para el tinte por oxidacion de las fibras queratinicas que comprende un alcohol graso que tiene mas de veinte atomos de carbono y un tensioactivo no ionico oxialquilenado de hlb superior a 5
BR0010555A (pt) Inibidores de neuraminidases
ES2192031T3 (es) Nuevas amidas aromaticas, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2154560B1 (es) Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.
PT1169337E (pt) Nitratos esteroides para o tratamento de lesoes oxidativas e disfuncoes endoteliais
AU4246501A (en) 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity
AR028624A1 (es) Heterociclilalquilaminas como antagonistas de receptores muscarinicos
PT1086097E (pt) Compostos sulfonilbenzeno como agentes anti-inflamatorios/analgesicos
DE60016181D1 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
PT1154979E (pt) Processo microbiano para a preparacao da pravastatina

Legal Events

Date Code Title Description
FD Application declared void or lapsed